Tisherman Samuel A, Alam Hasan B, Rhee Peter M, Scalea Thomas M, Drabek Tomas, Forsythe Raquel M, Kochanek Patrick M
From the University of Maryland School of Medicine (S.A.T., T.M.S.), R Adams Cowley Shock Trauma Center, Baltimore, Maryland; Department of Surgery (H.B.A.), University of Michigan, Ann Arbor, Michigan; Department of Surgery (P.M.R.), Emory University, Atlanta, Georgia; Department of Anesthesiology (T.D.), University of Pittsburgh, Pittsburgh, Pennsylvania; Department of Surgery (R.M.F.), University of Pittsburgh, Pittsburgh, Pennsylvania; and Department of Critical Care Medicine (P.M.K.), University of Pittsburgh, Pittsburgh, Pennsylvania.
J Trauma Acute Care Surg. 2017 Nov;83(5):803-809. doi: 10.1097/TA.0000000000001585.
Patients who suffer a cardiac arrest from trauma rarely survive, even with aggressive resuscitation attempts, including an emergency department thoracotomy. Emergency Preservation and Resuscitation (EPR) was developed to utilize hypothermia to buy time to obtain hemostasis before irreversible organ damage occurs. Large animal studies have demonstrated that cooling to tympanic membrane temperature 10°C during exsanguination cardiac arrest can allow up to 2 hours of circulatory arrest and repair of simulated injuries with normal neurologic recovery.
The Emergency Preservation and Resuscitation for Cardiac Arrest from Trauma trial has been developed to test the feasibility and safety of initiating EPR. Select surgeons will be trained in the EPR technique. If a trained surgeon is available, the subject will undergo EPR. If not, the subject will be followed as a control subject. For this feasibility study, 10 EPR and 10 control subjects will be enrolled.
Study participants will be those with penetrating trauma who remain pulseless despite an emergency department thoracotomy.
Emergency Preservation and Resuscitation will be initiated via an intra-aortic flush of a large volume of ice-cold saline solution. Following surgical hemostasis, delayed resuscitation will be accomplished with cardiopulmonary bypass.
The primary outcome will be survival to hospital discharge without significant neurologic deficits. Secondary outcomes include long-term survival and functional outcome.
Once data from these 20 subjects are reviewed, revisions to the inclusion criteria and/or the EPR technique may then be tested in a second set of EPR and control subjects.
因创伤导致心脏骤停的患者即使接受积极的复苏尝试,包括急诊开胸手术,也很少能存活。紧急保存与复苏(EPR)技术旨在利用低温争取时间,在不可逆的器官损伤发生前实现止血。大型动物研究表明,在放血致心脏骤停期间将鼓膜温度降至10°C,可允许长达2小时的循环骤停,并在神经功能正常恢复的情况下修复模拟损伤。
创伤性心脏骤停紧急保存与复苏试验旨在测试启动EPR的可行性和安全性。选定的外科医生将接受EPR技术培训。如果有经过培训的外科医生,受试者将接受EPR。如果没有,则将受试者作为对照进行随访。对于这项可行性研究,将招募10名接受EPR的受试者和10名对照受试者。
研究参与者将是那些穿透性创伤患者,尽管进行了急诊开胸手术,但仍无脉搏。
通过主动脉内注入大量冰冷盐溶液启动紧急保存与复苏。手术止血后,将通过体外循环进行延迟复苏。
主要观察指标将是存活至出院且无明显神经功能缺损。次要观察指标包括长期存活和功能转归。
一旦对这20名受试者的数据进行审查,纳入标准和/或EPR技术的修订可能会在另一组接受EPR的受试者和对照受试者中进行测试。